These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8183761)

  • 21. Double parathyroid carcinoma.
    Kameyama K; Takami H
    Endocr J; 2003 Aug; 50(4):477-9. PubMed ID: 14599124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of pamidronate in PTHrP associated hypercalcaemia in infancy.
    Buckmaster A; Rodda C; Cowell CT; Ogle G; Dorney S
    J Pediatr Endocrinol Metab; 1997; 10(3):301-4. PubMed ID: 9388823
    [No Abstract]   [Full Text] [Related]  

  • 23. Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.
    Singer FR; Neer RM; Murray TM; Keutmann HT; Deftos LJ; Potts JT
    N Engl J Med; 1970 Sep; 283(12):634-6. PubMed ID: 5450637
    [No Abstract]   [Full Text] [Related]  

  • 24. An audit of the management of malignant hypercalcaemia.
    Gerrard GE; Dodwell DJ; Vail A; Watters J; Overend MA
    Clin Oncol (R Coll Radiol); 1996; 8(1):39-42. PubMed ID: 8688360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
    Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
    Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
    McIntyre HD; Cameron DP; Urquhart SM; Davies WE
    Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
    Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
    Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism].
    Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A
    Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.
    Fountas A; Andrikoula M; Giotaki Z; Limniati C; Tsakiridou E; Tigas S; Tsatsoulis A
    Endocr Pract; 2015 May; 21(5):468-73. PubMed ID: 25667369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
    MacConnachie AM
    Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.
    Gurney H; Kefford R; Stuart-Harris R
    Lancet; 1989 Jul; 2(8657):241-4. PubMed ID: 2569054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy.
    Gallacher SJ; Fraser WD; Logue FC; Dryburgh FJ; Cowan RA; Boyle IT; Ralston SH
    Calcif Tissue Int; 1992 Dec; 51(6):419-23. PubMed ID: 1333351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I
    Minerva Endocrinol; 1984; 9(1):47-8. PubMed ID: 6239086
    [No Abstract]   [Full Text] [Related]  

  • 34. Refractory hypercalcaemia. Parathyroid adenoma or multiple myeloma?
    Dalgleish AG; Gatenby PA
    Med J Aust; 1984 Jan; 140(2):99-100. PubMed ID: 6694588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stilboestrol diphosphate in hypercalcaemia due to parathyroid carcinoma.
    Sigurdsson G; Woodhouse NJ; Taylor S; Joplin GF
    Br Med J; 1973 Jan; 1(5844):27-8. PubMed ID: 4683634
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy.
    Szmuilowicz ED; Utiger RD
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):291-6; quiz 297. PubMed ID: 16932300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
    J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia.
    Nesković-Konstantinović Z; Mitrović L; Petrović J; Stamatović L; Ristović Z
    Support Care Cancer; 1995 Nov; 3(6):422-4. PubMed ID: 8564348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
    Warrell RP; Issacs M; Alcock NW; Bockman RS
    Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid carcinoma should be suspected in dialysis patients with rapid changes in serum parathormone levels.
    Pineda E; Perez-Ordonez B; Dackiw A; Jassal SV
    Perit Dial Int; 2005; 25(1):93-4. PubMed ID: 15770934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.